Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06805513 · ClinicalTrials.gov registry record · Phase 3
Actual Use Trial of Tadalafil 5 mg
A Phase 3 study of Erectile Dysfunction, sponsored by Sanofi.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 2,250
- Enrollment target
- 1
- Study location
NCT06805513 is a Phase 3 study of Erectile Dysfunction that is actively recruiting participants, run by Sanofi. The registered enrollment target is 2,250 participants, above the 163-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (1280% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06805513, a Phase 3 study of Erectile Dysfunction, is actively recruiting participants, sponsored by Sanofi.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 2,250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this actual use trial (AUT) is to evaluate if participants can appropriately select and use the study product \[Cialis over the counter (OTC)\] using the labeling and the mandatory health survey assessment (HSA) for duration of 4-months.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Tadalafil 5 mg tablets with a digital tool.
Study Locations (1)
Utah
- Pegus - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,250 participants |
| Start Date | 2025-01-30 |
| Est. Completion | 2026-02-28 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06805513
The ClinicalTrials.gov registry entry for NCT06805513 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 2,250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 163-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (1280% higher). The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Tadalafil 5 mg tablets with a digital tool. is the first listed.
NCT06805513 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT06805513 about?
NCT06805513 is a clinical study titled "Actual Use Trial of Tadalafil 5 mg". The purpose of this actual use trial (AUT) is to evaluate if participants can appropriately select and use the study product \[Cialis over the counter (OTC)\] using the labeling and the mandatory health survey assessment (HSA) for duration of 4-months.
What is the current status of trial NCT06805513?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 2,250 participants. The study started on 2025-01-30. Estimated completion is 2026-02-28.
What conditions does trial NCT06805513 study?
This clinical trial studies the following conditions: Erectile Dysfunction.
What interventions are being tested in trial NCT06805513?
The interventions under investigation include: Tadalafil 5 mg tablets with a digital tool. (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06805513?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06805513 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
RECRUITING · Phase 3
-
Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement
ACTIVE NOT RECRUITING · Phase 3
-
An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms
COMPLETED · Phase 3
-
Treatment of Erectile Dysfunction II
COMPLETED · Phase 3
-
Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer
COMPLETED · Phase 3
-
Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.